Co-Authors
This is a "connection" page, showing publications co-authored by Carol Coupland and Julia Hippisley-Cox.
Connection Strength
9.569
-
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021 08 26; 374:n1931.
Score: 0.964
-
The Authors' reply. Heart. 2021 01; 107(1):85-86.
Score: 0.913
-
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020 Nov 05.
Score: 0.912
-
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019 Aug 01; 179(8):1084-1093.
Score: 0.835
-
Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database. BMC Med. 2018 03 08; 16(1):36.
Score: 0.758
-
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study. BMJ. 2017 Nov 20; 359:j5019.
Score: 0.743
-
Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study. BMJ. 2017 Sep 20; 358:j4208.
Score: 0.734
-
Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study. BMJ. 2017 Jun 15; 357:j2497.
Score: 0.721
-
Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. BMJ. 2011 Jan 04; 344:d8009.
Score: 0.461
-
Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England. JAMA Pediatr. 2021 09 01; 175(9):928-938.
Score: 0.241
-
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study. Lancet Infect Dis. 2021 11; 21(11):1518-1528.
Score: 0.238
-
An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England. Lancet Digit Health. 2021 07; 3(7):e425-e433.
Score: 0.237
-
Quantifying the association between ethnicity and COVID-19 mortality: a national cohort study protocol. BMJ Open. 2021 04 07; 11(4):e045286.
Score: 0.235
-
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 08; 9(8):909-923.
Score: 0.234
-
The Use of Primary Care Big Data in Understanding the Pharmacoepidemiology of COVID-19: A Consensus Statement From the COVID-19 Primary Care Database Consortium. Ann Fam Med. 2021 Mar-Apr; 19(2):135-140.
Score: 0.233
-
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults. Ann Intern Med. 2021 04; 174(4):572-576.
Score: 0.227
-
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020 10 20; 371:m3731.
Score: 0.227
-
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020 10; 106(19):1503-1511.
Score: 0.224
-
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. BMJ. 2018 07 04; 362:k2505.
Score: 0.194
-
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017 May 23; 357:j2099.
Score: 0.179
-
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study. Ann Intern Med. 2021 10; 174(10):1483-1487.
Score: 0.060